C-3.18.5. References

  1. Trujillo J, Haines S. Diabetes Mellitus. In: DiPiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V. DiPiro J.T., & Yee G.C., & Posey L, & Haines S.T., & Nolin T.D., & Ellingrod V(Eds.),Eds. Joseph T. DiPiro, et al.eds. Pharmacotherapy: A Pathophysiologic Approach, 11e. McGraw Hill; 2020. Accessed September 13, 2021. https://accesspharmacy-mhmedical-com.ezproxy.lib.utexas.edu/content.aspx?bookid=2577&sectionid=228901946
  2. Garber AJ, Handelsman Y, Grunberger, et. al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm- 2020 executive summary. Endocr Pract. 2020 Jan;26(1):107-139. doi: 10.4158/CS-2019-0472. PMID: 32022600.
  3. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment. Diabetes Care. 2021;44 (Suppl 1):S111-124.
  4. Weinstock RS. General principles of insulin therapy in diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed September 13, 2021.)
  5. Weinstock RS. Management of blood glucose in adults with type 1 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed September 13, 2021.)
  6. Levitsky LL, Misra M. Management of type 1 diabetes mellitus in children and adolescents. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed September 13, 2021.)
  7. Wexler JW. Insulin therapy in type 2 diabetes mellitus. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed September 13, 2021.)
  8. American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes – 2021. Diabetes Care. 2021;44 (Suppl 1): dc21-S0006. 
  9. American Diabetes Association. 13. Children and adolescents: Standards of medical care in diabetes – 2021. Diabetes Care. 2021;44 (Suppl 1)S180-S199.
  10. IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited: September 13, 2021).
  11. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2021. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 13, 2021.
  12. Lexicomp OnlineTM. Lexi-Comp OnlineTM. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2021. Available at: http://online.lexi.com.ezproxy.lib.utexas.edu. Accessed September 13, 2021.
  13. Facts and Comparisons eAnswers [database online]. Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2021; Accessed September 1, 2021.
  14. Insulin aspart (Fiasp®) package insert. NovoNordisk, December 2019.
  15. Insulin aspart (NovoLog®) package insert. Novo Nordisk, March 2021.
  16. Insulin glulisine (Apidra®) package insert. Sanofi-Aventis, November 2020.
  17. Insulin lispro (Admelog®) package insert. Sanofi-Aventis, November 2020.
  18. Insulin lispro (Humalog®) package insert. Eli Lilly, May 2021.
  19. Insulin lispro (Lyumjev®) package insert. Eli Lilly and Company, August 2021.
  20. Regular insulin (Afrezza®) package insert. MannKind Corporation, March 2021.
  21. Regular insulin (Humulin® R) package insert. Eli Lilly, March 2020.
  22. Regular insulin (Humulin® R Concentrated U 500) package insert. Eli Lilly, November 2020.
  23. Regular insulin (Novolin® R) package insert. Novo Nordisk, November 2019.
  24. Insulin isophane (NPH) (Humulin® N) package insert. Eli Lilly, November 2020.
  25. Insulin isophane (NPH) (Novolin® N) package insert. Novo Nordisk, November 2019.
  26. Insulin degludec (Tresiba®) package insert. Novo Nordisk, November 2019.
  27. Insulin detemir (Levemir®) package insert. Novo Nordisk, April 2021.
  28. Insulin glargine (Basaglar®) package insert. Eli Lilly, July 2021.
  29. Insulin glargine (Lantus®) package insert. Sanofi-Aventis, January 2021.
  30. Insulin glargine (Semglee®) package insert. Mylan Specialty LP, June 2020.
  31. Insulin glargine (Toujeo®) package insert. Sanofi-Aventis, December 2020.
  32. Insulin aspart protamine and insulin aspart (NovoLog® Mix 70/30) package insert. Novo Nordisk, April 2021.
  33. Insulin isophane (NPH) and regular (Humulin® 70/30) package insert. Eli Lilly, November 2020.
  34. Insulin isophane (NPH) and regular (Novolin® 70/30) package insert. Novo Nordisk, November 2019.
  35. Insulin lispro (Humalog® Mix 50/50) package insert. Eli Lilly, March 2021.
  36. Insulin lispro (Humalog® Mix 75/25) package insert. Eli Lilly, June 2021.
  37. Insulin glargine and lixisenatide (Soliqua® 100/33) package insert. Sanofi-Aventis, August 2021.
  38. Insulin degludec and liraglutide (Xultophy® 100/3.6) package insert. Novo Nordisk, November 2019.
  39. Melillo G. FDA approves Fiasp for children with diabetes. Am J Manag Care. January 6, 2020. Available at: www.ajmc.com/view/fda-approves-fiasp-for-children-with-diabetes. Accessed September 13, 2021.